Example: Heart Attack

Search clinical trials for: Prescriptive Infusion Algorithm

Total 6211 results

NCT04099381

Recruiting

Safety and Efficacy of the Transfusion of UCB in Patients With an ASD Depending on the Degree of HLA Compatibility. (ASD-HLA2019)

Autism Spectrum Disorder | Autism
NCT05292625

Completed

Stem Cell Infusion in the Treatment of Patients with Neurological Sequelae After Ischemic Stroke

Ischemic Stroke
NCT01719640

Completed

MSC and MC in Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
NCT03850574

Recruiting

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia (TUSCANY)

Leukemia, Myeloid, Acute | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome With Excess Blasts-2 | Relapsed Adult AML | Refractory AML
NCT01407237

Completed

Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV

HIV-infection
NCT01198925

Completed

Assessment of the Optimal Dosing of Piperacillin-tazobactam in Intensive Care Unit Patients: Extended Versus Continuous Infusion

Infectious Disease
NCT01720940

Unknown

Reducing Nephrotoxicity of Vancomycin: A Prospective Study of Continuous Versus Intermittent Infusion of Vancomycin

Infections Requiring Prolonged Duration (>10 Days) of Vancomycin
NCT01110252

Completed

Safety Study of Cell Therapy to Treat Chronic Obstructive Pulmonary Disease (COPD-01)

Chronic Obstructive Pulmonary Disease | Pulmonary Emphysema
NCT01072435

Completed

Target-controlled Infusion Versus Patient-controlled Sedation With Propofol in Endoscopic Retrograde Cholangiopancreatography (ERCP)

Sedation
NCT07365059

Not yet recruiting

Safety and Efficacy of GPRC5D CAR-T Cell Therapy in Relapsed/Refractory Plasma Cell Disorders

Plasma Cell Dyscrasias
NCT05739188

Recruiting

Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM

Multiple Myeloma in Relapse | Multiple Myeloma, Refractory
NCT05686538

Recruiting

Innate Donor Effector Allogeneic Lymphocyte Infusion After Stem Cell Transplantation: the IDEAL Trial (IDEAL)

AML/MDS
NCT02633124

Terminated

Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants. (MultilineNEO)

Bacteremia | Infant, Very Low Birth Weight
NCT06538844

Completed

Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Reperfusion Therapy

Acute Ischemic Stroke
NCT04582864

Terminated

Flotetuzumab for Relapsed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Following Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)

Relapsed Acute Myeloid Leukemia
NCT02612155

Completed

A Multi-site Study of Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy ((HIE))

Moderate or Severe Hypoxic-ischemic Encephalopathy in Newborns
NCT03660332

Completed

The Effect of an Acute Increase in Plasma IL-6 on Glucose Tolerance When a Meal is Administered Intraduodenally (DUIL-6)

Postprandial Glucose Homeostasis
NCT05030376

Completed

Intraileal Glucose vs. Saline Infusion on Hormone Secretion and Glycemic Excursions

Incretins
NCT01818427

Completed

PreHospital Air Medical Plasma Trial (PAMPer)

Hemmorhagic Shock During Air Medical Transport
NCT02547948

Withdrawn

CD19-targeting CAR T Cells for B Cell Lymphoma

B Cell Lymphoma
NCT01851343

Terminated

Bone Marrow Stromal Cells for Inflammatory Bowel Diseases

Inflammatory Bowel Disease
NCT00275977

Unknown

Treatment of Myocardial Infarction With Bone Marrow Derived Stem Cells

Acute Myocardial Infarction
NCT06902675

Active, not recruiting

Artificial Intelligence as a Decision Making Tool in Emergency Department

Clinical Decision-making | Electronic Health Records | Emergency Department Visit | Information Systems | Medical Reporting | Artificial Intelligence in Medicine
NCT02945241

Completed

Cystatin-C C-guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project

Sepsis | Critical Illness | Methicillin-resistant Staphylococcus Aureus
NCT06044571

Recruiting

Optimizing Telehealth-delivery of a Weight Loss Intervention in Older Adults

Obesity | Multiple Chronic Conditions
NCT03354390

Active, not recruiting

HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma

Kidney Cancer
NCT05172453

Recruiting

Mother-to-child Transmission of HBV in China

Hepatitis B, Chronic | Mother to Child Transmission
NCT06507384

Completed

AI Risk Assessment Model for Complication Prevention in Plastic Surgery (Artificial Intelligence) (AI)

Risk Factors | Risk Assessment
NCT02267408

Terminated

Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Unstable Warfarin

Hypoprothrombinemia
NCT00572533

Completed

Intelligent Control Approach to Anemia Management

End-Stage Renal Disease
NCT01379547

Unknown

Procalcitonin to Shorten Antibiotics Duration in ICU Patients (ProShort)

Sepsis
NCT04605978

Completed

Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients

Primary Sjögren's Syndrome
NCT04044820

Recruiting

Opioid Use Post-Discharge After Ambulatory Distal Arm Surgery

Opioid Use
NCT05454644

Completed

Effectiveness of a Person-centred Prescription Model at the End of Life

Geriatrics | Inappropriate Prescribing | Palliative Medicine | Deprescriptions | End-Of-Life
NCT03662438

Unknown

HOPE (Home-based Oxygen [Portable] and Exercise) for Patients on Long Term Oxygen Therapy (LTOT) (HOPE)

Physical Activity | Respiratory Failure | Exercise Therapy | Oxygen Inhalation Therapy
NCT05786768

Recruiting

Efficacy and Safety of Obinutuzumab Versus Rituximab in Childhood Steroid Dependant and Frequent Relapsing Nephrotic Syndrome (OBIRINS)

Steroid-Dependent Nephrotic Syndrome | Steroid-Sensitive Nephrotic Syndrome
NCT06542198

Completed

Mannitol-induced Release of Copeptin in Healthy Adults and Patients With Polyuria-Polydipsia Syndrome (MARS Study) (MARS)

Polyuria-polydipsia Syndrome | Primary Polydipsia | Arginine Vasopressin Deficiency
NCT00682565

Completed

PK and Tolerability of IV and Oral CK-1827452 in Patients With Ischemic Cardiomyopathy and Angina

Myocardial Ischemia | Heart Failure | Angina Pectoris
NCT01186809

Completed

Cytokine Induced Killer (CIK) Cells In Leukemia Patients (CIK2)

Hematologic Malignancies
NCT06707935

Recruiting

Mental Health Help-seeking Promotion in Older Adults

Mental Health Help-seeking
NCT05957601

Recruiting

The Relationship Between the Parameters Affecting the Functionality of the Pelvic Floor and the Temporomandibular Joint

Temporomandibular Joint Disorders | Pelvic Floor Disorders
NCT05692479

Completed

Premenstrual Syndrome and Physical Activity Self-Worth

Premenstrual Syndrome
NCT03429283

Completed

Achromobacter Xylosoxidans (ACHX) Infections (ACHX)

Nosocomial Infection
NCT01829581

Completed

geRman-widE mulTicenter Analysis of oRal Anticoagulation-associated intraCerebral hEmorrhage (RETRACE)

OAC-ICH | Acute Management of OAC-ICH | Resumption of OAC
NCT07338604

Recruiting

Clinical Study of UTAA07 Injection in the Treatment of Hematologic and Lymphatic Systemic Malignancies

Hematolymphoid Malignancies
NCT06503497

Recruiting

A Trail of Second-line Chemotherapy Sequential NKG2D CAR-NK Cell Therapy for Pancreatic Cancer

Pancreatic Cancer Non-resectable
NCT06121323

Completed

Physiological Effects of Lactate in Individuals With Chronic Heart Failure

Heart Failure, Systolic
NCT06037265

Completed

PR-0164 First in Human Clinical Trial of the PAVmed PortIO Intraosseous Infusion System

Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Poor Vascular Access
NCT02851940

Withdrawn

Pain and Bleeding Following Hypertonic Saline Sclerotherapy Compared to Brand Ligation for Symptomatic Hemorrhoids

Pain | Bleeding | Hemorrhoids
NCT03231917

Completed

Water Immersion and Polyp Detection: A Randomized Controlled Trial

Adenoma | Colonic Neoplasms

Search clinical trials for: Prescriptive Infusion Algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations